Past Award Recipients:

Arthur M. Sutherland Award and Memorial Lecture

  • 2025 – Yosuke Uchitomi (Japan)
    Dr. Uchitomi has made significant contributions to the field of psycho-oncology and is recognized globally as a leader in this discipline. He is world renown for his scientific achievements, leadership, mentorship and contributions to IPOS and the entire field of Psycho-oncology. He played a pivotal role in the establishment of the Japanese Psycho-Oncology Society (JPOS), thereby laying the groundwork for advancing psychosocial care in oncology throughout Japan. In addition to his national impact, Dr. Uchitomi was instrumental as a founding member of the Asian Psycho-Oncology Society (APPON), promoting collaboration and research excellence in psycho-oncology across the region. His dedication to enhancing cancer care renders this prestigious award nomination well-deserved.
  • 2024 – Harvey Max Chochinov (Canada)
  • 2023 – Barbara Andersen (USA)

  • 2022 – Dr. Maria Die Trill (Spain)
  • 2020/2021 – Dr. Paul Jacobsen (USA)
  • 2018 – Professor Richard Fielding (Hong Kong)
  • 2017 – Professor Matthew Loscalzo (USA)
  • 2016 – Dr. Barry Bultz (Canada)
  • 2015 – Dr William Redd (USA)
  • 2014 – Christoffer Johansen (Denmark)
  • 2013 – Maggie Watson (UK)
  • 2012 – Luigi Grassi* (Italy)
  • 2011 – David Spiegel (USA)
  • 2009 – William Breitbart (USA)
  • 2008 – David Kissane (Australia)
  • 2007 – Uwe Koch
  • 2006 – Peter Maguire
  • 2004 – Lea Baider (Israel)
  • 2003 – Jimmie Holland  (USA)
  • 2000 – Robert Zittoun
  • 1998 – Hiroomi Kawano
  • 1996 – Steven Greer
  • 1993 – Ned Cassem
  • 1991 – Margit von Kerekjarto
  • 1987 – Morton Bard
  • 1984 – Bernard Fox
  • 1982 – Avery Weisman

 

Bernard Fox Memorial Award

  • 2025 – Joanne Shaw (Australia)
    Dr. Joanne Shaw, a health services and implementation scientist, is a pre-eminent leader in the field of psycho-oncology research.  She is a true translational scientist, able to take basic findings (T1), generate hypotheses and testing these (T2), run confirmatory interventions trials (T3), and disseminate findings across settings (T4). Those who can show their work spans the translational continuum are vanishingly rare in psycho-oncology. Her many outstanding contributions to psycho-oncology include:  her dedicated leadership of the Australian Psycho-Oncology Research Group; co-development and testing of clinical practice guidelines for management of anxiety and depression after cancer; and seminal research among cancer caregivers with regard to their fear of cancer recurrence in a loved. Dr. Shaw also has outstanding research outputs, which is evidenced by 126 peer-reviewed papers, covering wide range of topics, many of which are highly-clinically-relevant (e.g. care for breaking bad news, clinical pathways of psychological distress, efficacy trials in psychological therapies for patients with cancer, implementation of evidence-based interventions, etc). Her research achievements are influential both nationally and internationally.
  • 2024 – Sophie Lebel (Canada)
  • 2023 – Anja Mehnert-Theuerkauf (Germany)
  • 2022  Dr. Electra Paskett (USA)
  • 2020/2021 – Dr. Mary Jane Esplen (Canada)
  • 2019 – Dr. Linda Carlson (Canada)
  • 2018 – Professor Brian Kelly (Australia)
  • 2017 – Dr. Gary Rodin (Canada)
  • 2016 – Kimlin Tam Ashing (USA)
  • 2015 – Dr. Susan Okjsberg Dalton (Denmark)
  • 2014 – Julia Rowland (USA)
  • 2013 – Hanneke de Haes
  • 2012 – Darius Razavi*
  • 2011 – Christoffer Johansen (Denmark)
  • 2010 – Harvey Max Chochinov (Canada)
  • 2009 – Phyllis Butow (Australia) and Ruth McCorkle
  • 2008 – Paul Jacobsen (USA)
  • 2007 – Joan Bloom (USA)
  • 2006 – Yosuke Uchitomi (Japan)
  • 2004 – Neil Aaronson (Netherlands) and David Cella
  • 2003 – Lydia Temoshok

Jimmie Holland Memorial Award Winner

  • 2025 – Luigi Grassi (Italy)
    Dr. Luigi Grassi is a professor, and since 2005, the chair of psychiatry at the University of Ferrara, Italy. He's also the chair of the Department of Biomedical and Specialty Surgical Sciences at the Ferrara university. Professor Grassi's wide-ranging research interests, dedicated expertise and exceptional commitment include the psychiatric and psychosocial dimensions of cancer, the prevalence, diagnosis and treatment of psychiatric comorbidity in patients with cancer and other life-threatening illnesses, cancer survivorship and rehabilitation psychiatry.  His extensive academic career includes prestigious positions, which illustrate his far-reaching academic work as well as his scientific recognition in the national and international psycho-oncology community. From 2006 to 2008 he was President of the International Psycho-Oncology Society (IPOS). He was President of the Italian Society of Psycho-Oncology (SIPO) from 2003 to 2011. Professor Luigi Grassi is author of more 200 publications, 40 chapters of books and six international books for Oxford University Press, Wiley, Springer. He was also the co-editor of the Italian Journal of Psycho-oncology from 1999 to 2011. Professor Luigi Grassi has made significant contributions to the field of psycho-oncology, particularly in enhancing the understanding and integration of psychological care within cancer treatment. His work emphasizes the importance of addressing the emotional and psychological needs of cancer patients, which is crucial for improving their overall quality of life and treatment adherence.

  • 2024 – Lea Baider (Israel)

  • 2023 – Maggie Watson (UK)

  • 2022 – Dr. Luzia Travado (Portugal)

  • 2020/2021 – Chioma Asuzu (Nigeria)
  • 2019 – William Breitbart (USA)

SPECIAL AWARDS

  • 2006 – Aruna Tole, Special Award for Outstanding Contributions to Clinical Care of Patients with Cancer

Hiroomi & Setsuko Kawano New Investigator Award

  • 2025 – Anna Singleton (Australia)
    Dr. Anna Singleton as outstanding research contributions, high citation impact, grants, and presentations and a very well-rounded profile. She is a strong candidate for the Hiroomi & Setsuko Kawano New Investigator Award due to her outstanding research contributions, professional attainment, and resilience in the field of psycho-oncology. Her research has been widely cited and recognized internationally, demonstrating both innovation and real-world impact. She has a well-rounded academic profile, balancing high-quality publications, multiple research grants, and international presentations. Additionally, Dr. Singleton has demonstrated leadership and mentorship, fostering collaboration and growth within the psycho-oncology community. Dr. Singleton’s ability to balance research, funding, mentorship, and international influence makes her the ideal recipient in comparison to other participants. She's clearly seen as a rising star with an impressive trajectory, including receiving the 2023 NSW Premier’s Award for Outstanding Early Career Researcher and being named one of Australia’s Top 25 Brilliant Women in Digital Health (TelstraHealth 2022; >100 applicants). For such an early EMCR, the impact on practice of her research is also impressive, with her EMPOWER-SMS program (from her PhD) already implemented in hospitals and adapted for patients with endometriosis and people living in remote and indigenous communities.

  • 2024 –  Jose Custers (The Netherlands)
  • 2023 – William Rosa (USA)
  • 2022 – Dr. Lauren Heathcote (UK/USA)
  • 2020/2021 – Dr. Joanna Fardell (Australia)
  • 2019 – Dr. Ursula Sansom-Daly (Australia)
  • 2018 – Dr. Fiona Schulte, PhD (Canada)
  • 2017 – Dr. Michelle Peate (Australia)
  • 2016 – Dr. Shane Sinclair (Canada)
  • 2015 – Dr. Katrina L Whittaker
  • 2014 – Sylvie Lambert (Canada)
  • 2013 – Mariko Asai
  • 2012 – Wendy Lichtenthal (USA) and Claire Wakefield (Australia)
  • 2011 – Nadine Kasparian (USA)
  • 2010 – Maiko Fujimori (Japan)
  • 2009 – Anja Mehnert (Germany) and Alex Mitchell (UK)
  • 2008 – Susan T. Vadaparampil
  • 2007 – Wendy Wing Tak Lam (Hong Kong)
  • 2006 – Linda Carlson (Canada)
  • 2004 – Bettina Meiser
  • 2003 – Craig White
  • 1998 – Christoffer Johansen (Denmark)
  • 1996 – Yosuke Uchitomi (Japan)
  • 1993 – Elizabeth Maunsell

 

Noemi Fisman Award for Lifetime Clinical Excellence

  • 2025 – Cristiane Decat Bergerot (Brazil)
    In her more than 20 years career, Dr. Cristiane Decat Bergerot has demonstrated extraordinary leadership in developing and implementing psycho-oncology services across Brazil. She has delivered psychosocial care to thousands of patients and their families, pioneered national distress screening programs, and elevated standards of care through her integration of clinical work, research, and education. Her international recognition, outstanding publication record, and mentorship of emerging clinicians have positioned her as a pioneering leader in global psycho-oncology. She is a devoted clinician, an international leader in psychosocial oncology, an excellent and fruitful researcher integrating clinical research and work. She is a pioneer in implementing biopsychosocial distress screening in low- and middle-income settings. Her career in psychology spans more than two decades, beginning in 2003 with clinical work in pediatric oncology and continuing through progressively impactful roles in adult oncology and recently in older adult psycho-social oncology across Brazil and in international societies. A dedicated clinician, educator, and researcher, Dr. Bergerot has authored numerous publications in prestigious journals. As a leader, she holds key positions in several global initiatives. Her influence continues to expand as she strives to improve psycho-oncology care across Latin America through strategic partnerships.

  • 2024 – Helen Greally (Ireland)
  • 2023 – Gil Goldzweig (Israel)
  • 2022 – Dr. Melissa Henry (Canada)
  • 2020/2021 – Dr. Jong-Heun Kim (South Korea) 
  • 2018 – Dr. Lili Tang, MD (China)
  • 2017 – Dr. Chun-Kai Fang
  • 2015 – Dr. Andrew Roth (USA)
  • 2014 – Matthew Loscalzo (USA)
  • 2013 – Andrea Farkas Patenaude (USA)
  • 2012 – David Wellisch
  • 2011 – Marguerite Lederberg
  • 2009 – Penelope Hopwood (UK)
  • 2008 – Maria Die-Trill (Spain)

 

Society Distinguished Life Fellowship Award

 

President’s Community Award for Distinguished Contributions to IPOS

  • 2019 Kim Thiboldeaux, Chief Executive Officer, Cancer Support Community 
  • 2017 – Dr. Andreas Ullrich, WHO – Noncommunicable Diseases and Mental Health Cluster
  • 2014 – Beth Diamond, President’s Community Award for Distinguished Contributions to IPOS



    *Funding support for 2012 Sutherland and Fox Awards was generously provided by Cancer Council Queensland.

    The IPOS Awards Committee shall select recipients of IPOS awards. If no suitable nominations are received, no awards will be given.

    International Psycho-Oncology Society
    1 - 189 Queen Street East
    Toronto, ON M5A 1S2

    244 Fifth Avenue, Suite L296
    New York, NY 10001

    T: +1 416-968-0260
    info@ipos-society.org



    Facebook Logo    twitter x logo    linkedin logo     linkedin logo

    © 2025 International Psycho-Oncology Society 

     Website powered by Funnel Communications Inc.